Wave Life Sciences Ownership | Who Owns Wave Life Sciences?
Wave Life Sciences Ownership Summary
Wave Life Sciences is owned by 13.69% institutional investors, 15.88% insiders, and 70.43% retail investors. Ra capital management is the largest institutional shareholder, holding 14.97% of WVE shares. BB Biotech AG Ord is the top mutual fund, with 2.18% of its assets in Wave Life Sciences shares.
WVE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Wave Life Sciences | 13.69% | 15.88% | 70.43% |
| Sector | Healthcare Stocks | 35.42% | 11.83% | 52.76% |
| Industry | Biotech Stocks | 35.46% | 11.78% | 52.76% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 26.98M | 14.97% | $195.57M |
| Gsk | 18.25M | 10.13% | $132.28M |
| Blackrock funding, inc. /de | 14.12M | 7.84% | $102.35M |
| Maverick capital | 10.16M | 5.64% | $73.67M |
| Blackrock | 6.74M | 5.21% | $33.63M |
| Price t rowe associates inc /md/ | 8.70M | 4.83% | $63.11M |
| Artal group | 4.57M | 3.53% | $22.79M |
| Driehaus capital management | 5.43M | 3.01% | $39.37M |
| Federated hermes | 5.32M | 2.95% | $38.55M |
| Fmr | 5.19M | 2.88% | $37.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| M28 capital management lp | 4.59M | 61.83% | $33.27M |
| Gsk | 18.25M | 22.08% | $132.28M |
| Pfizer | 1.88M | 5.00% | $11.93M |
| Stempoint capital lp | 2.11M | 3.09% | $15.45M |
| Ra capital management | 26.98M | 2.07% | $195.57M |
| 683 capital management | 4.90M | 1.85% | $35.52M |
| Bioimpact capital | 1.51M | 1.80% | $11.02M |
| Scientech research | 200.33K | 1.21% | $1.45M |
| First light asset management | 1.84M | 1.20% | $13.37M |
| Maverick capital | 10.16M | 0.85% | $73.67M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 26.98M | 2.07% | 8.77M |
| Marshall wace, llp | 1.79M | 0.01% | 1.79M |
| Blackrock funding, inc. /de | 14.12M | 0.00% | 1.47M |
| Citadel advisors | 2.20M | 0.00% | 1.41M |
| Price t rowe associates inc /md/ | 8.70M | 0.01% | 1.30M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 5.19M | 0.00% | -9.94M |
| Adage capital partners gp | 1.00M | 0.01% | -8.79M |
| Darwin global management | - | - | -7.30M |
| Loomis sayles & co l p | - | - | -2.04M |
| Bellevue group | 5.26K | 0.00% | -1.49M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 878.83K | 0.00% | 878.83K | $6.37M |
| Point72 asset management | 663.97K | 0.01% | 663.97K | $4.86M |
| Abrdn | 550.00K | 0.01% | 550.00K | $3.99M |
| Aquatic capital management | 323.57K | 0.07% | 323.57K | $2.35M |
| Capital fund management | 183.33K | 0.01% | 183.33K | $1.33M |
Sold Out
| Holder | Change |
|---|---|
| Hughes financial services | -1.00 |
| National bank of canada /fi/ | -1.00 |
| Nelson, van denburg & campbell wealth management group | -12.00 |
| Capital performance advisors llp | -13.00 |
| Corecap advisors | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 89 | -62.45% | 24,665,832 | -86.50% | 13 | 0.12% | 56 | -62.16% | 18 | -63.27% |
| Dec 31, 2025 | 141 | -31.88% | 83,339,412 | -42.00% | 49 | 0.65% | 84 | -12.50% | 32 | -49.21% |
| Sep 30, 2025 | 205 | 17.14% | 143,685,835 | 5.73% | 87 | 1.28% | 96 | -7.69% | 61 | 56.41% |
| Jun 30, 2025 | 181 | -11.27% | 138,844,683 | 5.73% | 84 | 1.30% | 106 | -9.40% | 41 | -21.15% |
| Mar 31, 2025 | 202 | 6.88% | 131,254,882 | 2.11% | 80 | 0.84% | 116 | -3.33% | 51 | 34.21% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BB Biotech AG Ord | 4.09M | 2.18% | - |
| PRIMECAP Odyssey Aggressive Growth | 3.76M | 1.96% | 211.65K |
| iShares Russell 2000 ETF | 3.27M | 1.70% | 27.59K |
| Federated Hermes Kaufmann R | 2.48M | 1.29% | -331.93K |
| Federated Hermes Kaufmann Growth | 2.48M | 1.29% | -331.93K |
| T. Rowe Price New Horizons | 2.29M | 1.21% | - |
| US Small-Cap Growth II Equity Comp | 2.29M | 1.21% | -2.34K |
| T. Rowe Price Health Sciences | 2.25M | 1.20% | 759.97K |
| Fidelity Small Cap Growth | 2.06M | 1.07% | 179.10K |
| Fidelity Growth Compy Commingled Pl S | 1.98M | 1.03% | 3.08K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 26, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $30.02M | |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $6.31M | |
| Mar 27, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $16.05M | |
| Mar 26, 2026 | RA CAPITAL MANAGEMENT, L.P. | Buy | $2.24M | |
| Feb 26, 2026 | Francis Chris | See Remarks | Sell | $270.18K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 4 | 8 |
| 2025 Q4 | 2 | 27 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 2 |
WVE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools